Gα_i2- and Gα_i3-Deficient Mice Display Opposite Severity of Myocardial Ischemia Reperfusion Injury

• David Köhler,

  Affiliation Department of Anesthesiology and Intensive Care Medicine, Institute of Experimental and Clinical Pharmacology and Toxicology, Eberhard Karls University Hospitals and Clinics, and Interfaculty Center of Pharmacogenomics and Drug Research, Tuebingen, Germany

  ⨯
• Vasudharani Devanathan,

  Affiliation Department of Pharmacology and Experimental Therapy, Institute of Experimental and Clinical Pharmacology and Toxicology, Eberhard Karls University Hospitals and Clinics, and Interfaculty Center of Pharmacogenomics and Drug Research, Tuebingen, Germany

  ⨯
• Claudia Bernardo de Oliveira Franz,

  Affiliation Department of Anesthesiology and Intensive Care Medicine, Institute of Experimental and Clinical Pharmacology and Toxicology, Eberhard Karls University Hospitals and Clinics, and Interfaculty Center of Pharmacogenomics and Drug Research, Tuebingen, Germany

  ⨯
• Therese Eldh,

  Affiliation Department of Pharmacology and Experimental Therapy, Institute of Experimental and Clinical Pharmacology and Toxicology, Eberhard Karls University Hospitals and Clinics, and Interfaculty Center of Pharmacogenomics and Drug Research, Tuebingen, Germany

  ⨯
• Ana Novakovic,

  Affiliation Department of Pharmacology and Experimental Therapy, Institute of Experimental and Clinical Pharmacology and Toxicology, Eberhard Karls University Hospitals and Clinics, and Interfaculty Center of Pharmacogenomics and Drug Research, Tuebingen, Germany

  ⨯
• Judith M. Roth,

  Affiliation Department of Anesthesiology and Intensive Care Medicine, Institute of Experimental and Clinical Pharmacology and Toxicology, Eberhard Karls University Hospitals and Clinics, and Interfaculty Center of Pharmacogenomics and Drug Research, Tuebingen, Germany

  ⨯
• Tiago Granja,

  Affiliation Department of Anesthesiology and Intensive Care Medicine, Institute of Experimental and Clinical Pharmacology and Toxicology, Eberhard Karls University Hospitals and Clinics, and Interfaculty Center of Pharmacogenomics and Drug Research, Tuebingen, Germany

  ⨯
• Lutz Birnbaumer,

  Affiliation Laboratory of Neurobiology, Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina, United States of America

  ⨯
• Peter Rosenberger,

  Affiliation Department of Anesthesiology and Intensive Care Medicine, Institute of Experimental and Clinical Pharmacology and Toxicology, Eberhard Karls University Hospitals and Clinics, and Interfaculty Center of Pharmacogenomics and Drug Research, Tuebingen, Germany

  ⨯
• Sandra Beer-Hammer ,

  * E-mail: sandra.beer-hammer@uni-tuebingen.de (SBH); bernd.nuernberg@uni-tuebingen.de (BN)

  Affiliation Department of Pharmacology and Experimental Therapy, Institute of Experimental and Clinical Pharmacology and Toxicology, Eberhard Karls University Hospitals and Clinics, and Interfaculty Center of Pharmacogenomics and Drug Research, Tuebingen, Germany

  ⨯
• Bernd Nürnberg

  * E-mail: sandra.beer-hammer@uni-tuebingen.de (SBH); bernd.nuernberg@uni-tuebingen.de (BN)

  Affiliation Department of Pharmacology and Experimental Therapy, Institute of Experimental and Clinical Pharmacology and Toxicology, Eberhard Karls University Hospitals and Clinics, and Interfaculty Center of Pharmacogenomics and Drug Research, Tuebingen, Germany

  ⨯